Association between biliopancreatic diseases and intestinal microbiota
Not Applicable
- Conditions
- biliopancreatic diseases
- Registration Number
- JPRN-UMIN000045233
- Lead Sponsor
- agoya University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who wish to be excluded from the study If the principal investigator or sub-investigator determines that the patient is ineligible to participate in the study for any other reason.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To clarify the relationship between biliopancreatic lesions and duodenal mucosal surface microbiota.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link intestinal microbiota to biliopancreatic diseases in JPRN-UMIN000045233?
How does gut microbiota modulation compare to standard-of-care for biliopancreatic disease management?
Which biomarkers in intestinal microbiota predict response to interventions for biliopancreatic diseases?
What adverse events are associated with gut microbiota-targeted therapies in biliopancreatic conditions?
Are there combination approaches involving probiotics and existing treatments for biliopancreatic diseases?